NEW YORK (Reuters Health) – For nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA), linezolid is more effective and better tolerated than the gold standard vancomycin, according to a randomized controlled trial.
MRSA accounts for 10% to 40% of cases of healthcare-associated...